Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Circulating microRNAs as stable blood-based markers for cancer detection
2008 Standout
Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis
2018
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Cancer statistics, 2022
2022 Standout
Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase
2015
Cancer statistics, 2023
2023 Standout
The effect of COVID certificates on vaccine uptake, health outcomes, and the economy
2022 StandoutNobel
N-linked Glycosylation Enrichment for In-depth Cell Surface Proteomics of Diffuse Large B-cell Lymphoma Subtypes
2013
Ambient temperature and subsequent COVID-19 mortality in the OECD countries and individual United States
2021
Cancer Statistics, 2021
2021 Standout
Circulating Nucleic Acids in Plasma or Serum (CNAPS) as Prognostic and Predictive Markers in Patients with Solid Neoplasias
2005
HA14-1, a small molecule Bcl-2 antagonist, induces apoptosis and modulates action of selected anticancer drugs in follicular lymphoma B cells
2005
Post-remission therapy for acute myeloid leukemia
2014
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
MYC on the Path to Cancer
2012 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis
2005
c-Myc-regulated microRNAs modulate E2F1 expression
2005 StandoutNature
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
2010
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
The molecular biology of head and neck cancer
2010 Standout
Acute leukemia as a secondary malignancy in children and adolescents: Current findings and issues
2008
Acute Myeloid Leukemia and the Position of Autologous Stem Cell Transplantation
2007
Targeting multidrug resistance in cancer
2006 Standout
The molecular biology of cancer
2000
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM
2004
A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia
2006
Causes and consequences of microRNA dysregulation in cancer
2009 Standout
Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
2019
Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes
2005
Oncomirs — microRNAs with a role in cancer
2006 Standout
MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma
2003
Circulating mutant DNA to assess tumor dynamics
2008 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Oxidative Stress in Cancer
2020 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
2013 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Multiplex PCR System for Rapid Detection of Pathogens in Patients with Presumed Sepsis – A Systemic Review and Meta-Analysis
2013
Therapy-Related Myeloid Leukemia
2008
The Epidemiology of Myelodysplastic Syndromes
2010
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
2010 Standout
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
2002
A microRNA polycistron as a potential human oncogene
2005 StandoutNature
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
Circulating nucleic acids (CNAs) and cancer—A survey
2006
Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines
2013
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Optimal therapy for acute lymphoblastic leukemia in adolescents and young adults
2011
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
2006 Standout
Physiological Signaling Functions of Reactive Oxygen Species in Stem Cells: From Flies to Man
2021
The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma
2006
Circulating nucleic acids in plasma/serum
2007
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
2017
Free circulating mRNA in plasma from breast cancer patients and clinical outcome
2008
Advances in the understanding of susceptibility to treatment‐related acute myeloid leukaemia
2007
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal
2017
Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia
2016
Myelodysplastic Syndromes Clinical Practice Guidelines in Oncology
2006
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461
2006
A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)
2020
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
2011
Acute Myeloid Leukemia
2015 Standout
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Multidrug resistance protein attenuates gemtuzumab ozogamicin–induced cytotoxicity in acute myeloid leukemia cells
2003
Apoptosis: A Review of Programmed Cell Death
2007 Standout
Dose Escalation Studies of Cytarabine, Daunorubicin, and Etoposide With and Without Multidrug Resistance Modulation With PSC-833 in Untreated Adults With Acute Myeloid Leukemia Younger Than 60 Years: Final Induction Results of Cancer and Leukemia Group B Study 9621
2004
Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review
2008
Clinical Trial Participation and Time to Treatment Among Adolescents and Young Adults With Cancer: Does Age at Diagnosis or Insurance Make a Difference?
2011
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
2006 Standout
Reduced Plasma RNA Integrity in Nasopharyngeal Carcinoma Patients
2006
The myth of the second remission of acute leukemia in the adult
2012
Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation
2012
Inhibition of Class I Phosphoinositide 3-Kinase Activity Impairs Proliferation and Triggers Apoptosis in Acute Promyelocytic Leukemia without Affecting Atra-Induced Differentiation
2009
Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma
2006
Invasive Candidiasis
2015 Standout
Cytokine Storm
2020 Standout
Transcriptional control of human p53-regulated genes
2008 Standout
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
2018 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
2008
Development of Minimal Residual Disease–Directed Therapy in Acute Myeloid Leukemia
2008
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Identification and Characterization of a Novel Gene, C13orf25 , as a Target for 13q31-q32 Amplification in Malignant Lymphoma
2004
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin
2004
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
2004 Standout
Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: state of the issue.
2004
BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma
2005
Proteomic cell surface phenotyping of differentiating acute myeloid leukemia cells
2010
CAR T cell immunotherapy for human cancer
2018 StandoutScience
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Chemical Glycoproteomics
2016 StandoutNobel
Stability of Endogenous and Added RNA in Blood Specimens, Serum, and Plasma
2002
Works of Mar Tormo being referenced
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors
2008
Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)
2013
Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention
2007
Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome
2003
Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group
2010
Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies
2007
Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia
2004
Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia
2019
Oxidative imbalance in low/intermediate-1-risk myelodysplastic syndrome patients: The influence of iron overload
2017
Darbepoetin α for the treatment of anemia in patients with myelodysplastic syndromes
2006
Profile of polymorphisms of drug‐metabolising enzymes and the risk of therapy‐related leukaemia
2007
Apoptotic Induction in Transformed Follicular Lymphoma Cells by Bcl-2 Downregulation
1998
Real-Time Quantification in Plasma of Human Telomerase Reverse Transcriptase (hTERT) mRNA: A Simple Blood Test to Monitor Disease in Cancer Patients
2001
Diagnostic accuracy and potential clinical value of the LightCycler SeptiFast assay in the management of bloodstream infections occurring in neutropenic and critically ill patients
2011
Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia
2006
Comparison of the Results of the Treatment of Adolescents and Young Adults With Standard-Risk Acute Lymphoblastic Leukemia With the Programa Español de Tratamiento en Hematología Pediatric-Based Protocol ALL-96
2008
Secondary Acute Myeloid Leukemia and Myelodysplastic Syndromes Following ATRA and Anthracycline Monochemotherapy Treatment for Acute Promyelocytic Leukemia.
2007
Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy
2013
Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma
2001
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin
2008
Darbepoetin Alfa for the Treatment of Anemia in Patients with Myelodysplastic Syndrome.
2005
Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocol.
2004
Immunophenotypic findings in acute myeloid leukemia with FLT3 internal tandem duplication.
2003
Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA.
2001
Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
2001